ATE237579T1 - Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament. - Google Patents
Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament.Info
- Publication number
- ATE237579T1 ATE237579T1 AT00110121T AT00110121T ATE237579T1 AT E237579 T1 ATE237579 T1 AT E237579T1 AT 00110121 T AT00110121 T AT 00110121T AT 00110121 T AT00110121 T AT 00110121T AT E237579 T1 ATE237579 T1 AT E237579T1
- Authority
- AT
- Austria
- Prior art keywords
- heptan
- bicyclo
- dimethylamino
- ethoxy
- tri
- Prior art date
Links
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/12—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9901559A HU227114B1 (en) | 1999-05-11 | 1999-05-11 | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE237579T1 true ATE237579T1 (de) | 2003-05-15 |
Family
ID=89998272
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00110121T ATE237579T1 (de) | 1999-05-11 | 2000-05-10 | Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament. |
| AT00110122T ATE246170T1 (de) | 1999-05-11 | 2000-05-10 | Verfahren zur herstellung von (1r, 2s, 4r)-(-)-2- ((2'-(n,n-dimethylamino)-ethoxy))-2-(phenyl)-1, , 7-tri-(methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze |
| AT00927613T ATE386714T1 (de) | 1999-05-11 | 2000-05-10 | Verfahren zur herstellung von (1r, 2s, 4r)-(-)-2- (2'-(n,n-dimethylamino)-ethoxy) -2- phenyl -1,7, 7-tri- methyl -bicyclo[2.2.1 heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze |
| AT00929730T ATE252544T1 (de) | 1999-05-11 | 2000-05-10 | Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament. |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00110122T ATE246170T1 (de) | 1999-05-11 | 2000-05-10 | Verfahren zur herstellung von (1r, 2s, 4r)-(-)-2- ((2'-(n,n-dimethylamino)-ethoxy))-2-(phenyl)-1, , 7-tri-(methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze |
| AT00927613T ATE386714T1 (de) | 1999-05-11 | 2000-05-10 | Verfahren zur herstellung von (1r, 2s, 4r)-(-)-2- (2'-(n,n-dimethylamino)-ethoxy) -2- phenyl -1,7, 7-tri- methyl -bicyclo[2.2.1 heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze |
| AT00929730T ATE252544T1 (de) | 1999-05-11 | 2000-05-10 | Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament. |
Country Status (37)
| Country | Link |
|---|---|
| US (3) | US6242386B1 (de) |
| EP (4) | EP1177166B1 (de) |
| JP (2) | JP4031203B2 (de) |
| KR (3) | KR20060010874A (de) |
| CN (2) | CN1173928C (de) |
| AR (2) | AR020860A1 (de) |
| AT (4) | ATE237579T1 (de) |
| AU (2) | AU777737B2 (de) |
| BG (2) | BG64442B1 (de) |
| BR (2) | BR0010406A (de) |
| CA (2) | CA2373193A1 (de) |
| CO (1) | CO5170480A1 (de) |
| CZ (4) | CZ20014051A3 (de) |
| DE (4) | DE60004126T2 (de) |
| DK (4) | DK1177166T3 (de) |
| EA (2) | EA002163B1 (de) |
| EE (2) | EE200100596A (de) |
| ES (4) | ES2302694T3 (de) |
| FR (2) | FR2793489B1 (de) |
| HR (2) | HRP20000290B1 (de) |
| HU (1) | HU227114B1 (de) |
| IL (4) | IL146420A0 (de) |
| IS (2) | IS6152A (de) |
| LT (2) | LT4927B (de) |
| MX (2) | MXPA01011423A (de) |
| MY (2) | MY122508A (de) |
| NO (2) | NO321486B1 (de) |
| NZ (2) | NZ515918A (de) |
| PL (2) | PL202956B1 (de) |
| PT (4) | PT1052243E (de) |
| SI (4) | SI1052245T1 (de) |
| SK (4) | SK6892000A3 (de) |
| TR (2) | TR200200147T2 (de) |
| TW (2) | TWI286541B (de) |
| UA (2) | UA49974C2 (de) |
| WO (2) | WO2000068183A2 (de) |
| ZA (2) | ZA200108956B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
| US6589996B2 (en) | 2000-03-17 | 2003-07-08 | Orion Corporation | Treatment of disorders relating to the serotonergic system |
| US20040082665A1 (en) * | 2001-01-22 | 2004-04-29 | Outi Maki-Ikola | Method for treating stress or tension |
| HUP0103017A3 (en) * | 2001-07-18 | 2004-05-28 | Egis Gyogyszergyar Nyilvanosan | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use |
| GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
| HUP0301906A3 (en) * | 2003-06-23 | 2006-03-28 | Egis Gyogyszergyar Nyilvanosan | Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity |
| HRP20060325A2 (en) * | 2004-03-12 | 2007-02-28 | Egis Gy�gyszergy�r Nyrt. | Combination of deramciclane and opoids as analgesics |
| JP4916680B2 (ja) * | 2005-06-30 | 2012-04-18 | 株式会社半導体エネルギー研究所 | 半導体装置の作製方法、剥離方法 |
| US20080258121A1 (en) * | 2007-04-23 | 2008-10-23 | Hasan Farooq | Fire Retardant Composition |
| PE20121187A1 (es) | 2009-11-19 | 2012-09-23 | Yissum Res Dev Co | Canfenos arilados con actividad sobre los receptores cb2 y procesos para su preparacion |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179164B (en) * | 1979-12-14 | 1982-08-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing cycloalkyl-ethers of alkanolamines |
| HU212574B (en) * | 1990-09-21 | 1996-08-29 | Egyt Gyogyszervegyeszeti Gyar | Process for producing (1r,2s)-(-)-2-phenyl-(2'-dimethyl-amino-etoxy)-1,7,7-trimethyl-bicyclo[2.2.1.]heptane |
| HU214588B (hu) * | 1994-07-01 | 1998-04-28 | EGIS Gyógyszergyár Rt. | Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására |
| HU226061B1 (en) | 1996-10-17 | 2008-04-28 | Egis Gyogyszergyar Nyilvanosan | 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation |
| HUP9900445A2 (hu) * | 1999-02-24 | 2001-06-28 | EGIS Gyógyszergyár Rt. | Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke |
| HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
-
1999
- 1999-05-11 HU HU9901559A patent/HU227114B1/hu not_active IP Right Cessation
-
2000
- 2000-05-10 CO CO00033730A patent/CO5170480A1/es not_active Application Discontinuation
- 2000-05-10 PT PT00110122T patent/PT1052243E/pt unknown
- 2000-05-10 DE DE60004126T patent/DE60004126T2/de not_active Expired - Fee Related
- 2000-05-10 HR HR20000290A patent/HRP20000290B1/xx not_active IP Right Cessation
- 2000-05-10 TR TR2002/00147T patent/TR200200147T2/xx unknown
- 2000-05-10 EP EP00927613A patent/EP1177166B1/de not_active Expired - Lifetime
- 2000-05-10 PL PL340108A patent/PL202956B1/pl not_active IP Right Cessation
- 2000-05-10 FR FR0005940A patent/FR2793489B1/fr not_active Expired - Fee Related
- 2000-05-10 CZ CZ20014051A patent/CZ20014051A3/cs unknown
- 2000-05-10 KR KR1020067001294A patent/KR20060010874A/ko not_active Ceased
- 2000-05-10 SI SI200030124T patent/SI1052245T1/xx unknown
- 2000-05-10 EP EP00110122A patent/EP1052243B1/de not_active Expired - Lifetime
- 2000-05-10 DE DE60038112T patent/DE60038112T8/de not_active Expired - Fee Related
- 2000-05-10 DK DK00927613T patent/DK1177166T3/da active
- 2000-05-10 BG BG104416A patent/BG64442B1/bg unknown
- 2000-05-10 KR KR1020017014355A patent/KR100581489B1/ko not_active Expired - Fee Related
- 2000-05-10 IL IL14642000A patent/IL146420A0/xx active IP Right Grant
- 2000-05-10 UA UA2000052641A patent/UA49974C2/uk unknown
- 2000-05-10 AT AT00110121T patent/ATE237579T1/de not_active IP Right Cessation
- 2000-05-10 PT PT00929730T patent/PT1177167E/pt unknown
- 2000-05-10 DE DE60006097T patent/DE60006097T2/de not_active Expired - Lifetime
- 2000-05-10 AT AT00110122T patent/ATE246170T1/de not_active IP Right Cessation
- 2000-05-10 NZ NZ515918A patent/NZ515918A/xx not_active IP Right Cessation
- 2000-05-10 EP EP00110121A patent/EP1052245B1/de not_active Expired - Lifetime
- 2000-05-10 CN CNB008082391A patent/CN1173928C/zh not_active Expired - Fee Related
- 2000-05-10 IL IL14642100A patent/IL146421A0/xx active IP Right Grant
- 2000-05-10 AR ARP000102244A patent/AR020860A1/es not_active Application Discontinuation
- 2000-05-10 EA EA200000410A patent/EA002163B1/ru not_active IP Right Cessation
- 2000-05-10 AR ARP000102239A patent/AR023900A1/es active IP Right Grant
- 2000-05-10 EP EP00929730A patent/EP1177167B1/de not_active Expired - Lifetime
- 2000-05-10 BR BR0010406-0A patent/BR0010406A/pt not_active Application Discontinuation
- 2000-05-10 US US09/569,050 patent/US6242386B1/en not_active Expired - Fee Related
- 2000-05-10 AT AT00927613T patent/ATE386714T1/de not_active IP Right Cessation
- 2000-05-10 AU AU47731/00A patent/AU777737B2/en not_active Ceased
- 2000-05-10 ES ES00927613T patent/ES2302694T3/es not_active Expired - Lifetime
- 2000-05-10 CN CNB008083576A patent/CN1325465C/zh not_active Expired - Fee Related
- 2000-05-10 CZ CZ20001723A patent/CZ291329B6/cs not_active IP Right Cessation
- 2000-05-10 EE EEP200100596A patent/EE200100596A/xx not_active IP Right Cessation
- 2000-05-10 JP JP2000617162A patent/JP4031203B2/ja not_active Expired - Fee Related
- 2000-05-10 SK SK689-2000A patent/SK6892000A3/sk unknown
- 2000-05-10 MY MYPI20002033A patent/MY122508A/en unknown
- 2000-05-10 SK SK1624-2001A patent/SK285780B6/sk not_active IP Right Cessation
- 2000-05-10 EE EEP200100595A patent/EE04638B1/xx not_active IP Right Cessation
- 2000-05-10 ES ES00110122T patent/ES2203373T3/es not_active Expired - Lifetime
- 2000-05-10 KR KR1020017014354A patent/KR100685071B1/ko not_active Expired - Fee Related
- 2000-05-10 SK SK1623-2001A patent/SK285635B6/sk not_active IP Right Cessation
- 2000-05-10 SI SI200030989T patent/SI1177166T1/sl unknown
- 2000-05-10 SK SK690-2000A patent/SK6902000A3/sk unknown
- 2000-05-10 WO PCT/HU2000/000044 patent/WO2000068183A2/en not_active Ceased
- 2000-05-10 UA UA2000052642A patent/UA61122C2/uk unknown
- 2000-05-10 PT PT00110121T patent/PT1052245E/pt unknown
- 2000-05-10 SI SI200030292T patent/SI1177167T1/xx unknown
- 2000-05-10 AU AU46003/00A patent/AU776696B2/en not_active Ceased
- 2000-05-10 DK DK00110121T patent/DK1052245T3/da active
- 2000-05-10 CZ CZ20001722A patent/CZ290734B6/cs not_active IP Right Cessation
- 2000-05-10 BG BG104417A patent/BG64673B1/bg unknown
- 2000-05-10 CA CA002373193A patent/CA2373193A1/en not_active Abandoned
- 2000-05-10 MX MXPA01011423A patent/MXPA01011423A/es active IP Right Grant
- 2000-05-10 PT PT00927613T patent/PT1177166E/pt unknown
- 2000-05-10 NZ NZ515917A patent/NZ515917A/xx unknown
- 2000-05-10 TR TR2002/00148T patent/TR200200148T2/xx unknown
- 2000-05-10 HR HR20000291A patent/HRP20000291B1/xx not_active IP Right Cessation
- 2000-05-10 JP JP2000617164A patent/JP4536265B2/ja not_active Expired - Fee Related
- 2000-05-10 DE DE60002117T patent/DE60002117T2/de not_active Expired - Lifetime
- 2000-05-10 TW TW089108901A patent/TWI286541B/zh not_active IP Right Cessation
- 2000-05-10 PL PL00340107A patent/PL340107A1/xx not_active IP Right Cessation
- 2000-05-10 DK DK00110122T patent/DK1052243T3/da active
- 2000-05-10 AT AT00929730T patent/ATE252544T1/de not_active IP Right Cessation
- 2000-05-10 SI SI200030219T patent/SI1052243T1/xx unknown
- 2000-05-10 CZ CZ20014050A patent/CZ20014050A3/cs unknown
- 2000-05-10 ES ES00929730T patent/ES2208328T3/es not_active Expired - Lifetime
- 2000-05-10 CA CA2369393A patent/CA2369393C/en not_active Expired - Fee Related
- 2000-05-10 WO PCT/HU2000/000043 patent/WO2000068181A2/en not_active Ceased
- 2000-05-10 FR FR0005941A patent/FR2793490B1/fr not_active Expired - Fee Related
- 2000-05-10 EA EA200000411A patent/EA002164B1/ru not_active IP Right Cessation
- 2000-05-10 US US09/569,046 patent/US6335469B1/en not_active Expired - Lifetime
- 2000-05-10 TW TW089108902A patent/TW528742B/zh not_active IP Right Cessation
- 2000-05-10 ES ES00110121T patent/ES2194643T3/es not_active Expired - Lifetime
- 2000-05-10 MX MXPA01011420A patent/MXPA01011420A/es active IP Right Grant
- 2000-05-10 BR BR0010412-4A patent/BR0010412A/pt not_active Application Discontinuation
- 2000-05-10 DK DK00929730T patent/DK1177167T3/da active
- 2000-05-10 MY MYPI20002032A patent/MY123523A/en unknown
-
2001
- 2001-10-30 US US09/984,542 patent/US6624201B2/en not_active Expired - Lifetime
- 2001-10-30 ZA ZA200108956A patent/ZA200108956B/en unknown
- 2001-10-30 ZA ZA200108958A patent/ZA200108958B/en unknown
- 2001-10-31 NO NO20015336A patent/NO321486B1/no not_active IP Right Cessation
- 2001-11-01 NO NO20015352A patent/NO321487B1/no unknown
- 2001-11-08 LT LT2001109A patent/LT4927B/lt not_active IP Right Cessation
- 2001-11-08 LT LT2001108A patent/LT4928B/lt not_active IP Right Cessation
- 2001-11-09 IS IS6152A patent/IS6152A/is unknown
- 2001-11-09 IS IS6153A patent/IS2570B/is unknown
- 2001-11-11 IL IL146420A patent/IL146420A/en not_active IP Right Cessation
- 2001-11-11 IL IL146421A patent/IL146421A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE248811T1 (de) | Indanylsubstituierte benzolcarbonamide, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltende pharmazeutische zubereitungen | |
| ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE50013167D1 (de) | 2'-substituierte 1,1'-biphenyl-2-carboxamide, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltende pharmazeutische zubereitungen | |
| ATE279392T1 (de) | Indol-verbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre medizinische anwendung | |
| DE50105386D1 (de) | Ortho, meta-substituierte bisarylverbindungen, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltende pharmazeutische zubereitungen | |
| ATE234291T1 (de) | Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung | |
| ATE233263T1 (de) | Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon | |
| ATE215951T1 (de) | Tetracyclische campothecineanalogue, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen | |
| DE60304599D1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE252544T1 (de) | Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament. | |
| ATE294175T1 (de) | 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
| DE60022890D1 (de) | Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen | |
| ATE264837T1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
| DE59912402D1 (de) | Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE264847T1 (de) | Verzweigte substituierte aminoderivate vom 3- amino-1-phenyl-1h(1,2,4)triazol, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATA156590A (de) | Mono-(2-ammonium-2-hydroxymethyl-1,3-propandiol (2r,cis)-1,2-epoxypropylphosphonat und verfahren zu dessen herstellung sowie pharmazeutische zusammensetzungen | |
| DE60200023D1 (de) | Isoindoloindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltende pharmazeutische Zusammensetzungen | |
| ATE275136T1 (de) | Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE60036081D1 (de) | (1-phenacyl-3-phenyl-3-piperidylethyl)piperidinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE60130676D1 (de) | Cyclohexyl(alkyl)-propanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE60007168D1 (de) | Benzopyranyl-guanidin-derivate, verfahren zu deren herstellung sowie diese enthaltenden pharmazeutische zusammensetzungen | |
| DE69924527D1 (de) | Arylalkanoylderivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zubereitungen | |
| DE60200041D1 (de) | Indenoindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltenden pharmazeutischen Zusammensetzungen | |
| DE60113278D1 (de) | Cumarin-derivate und ihre salze, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1052245 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |